More articles from The State of the Art

Open Access
Imaging Cancer Metabolism: Underlying Biology and Emerging Strategies
Austin R. Pantel, Daniel Ackerman, Seung-Cheol Lee, David A. Mankoff and Terence P. Gade

Journal of Nuclear Medicine September 1, 2018, 59 (9) 1340-1349; DOI: https://doi.org/10.2967/jnumed.117.199869
You have access
The Immunoimaging Toolbox
Aaron T. Mayer and Sanjiv S. Gambhir

Journal of Nuclear Medicine August 1, 2018, 59 (8) 1174-1182; DOI: https://doi.org/10.2967/jnumed.116.185967
You have access
A Perspective on the Evolving Story of PSMA Biology, PSMA-Based Imaging, and Endoradiotherapeutic Strategies
Denise S. O’Keefe, Dean J. Bacich, Steve S. Huang and Warren D.W. Heston

Journal of Nuclear Medicine July 1, 2018, 59 (7) 1007-1013; DOI: https://doi.org/10.2967/jnumed.117.203877
You have access
Imaging of Nonprostate Cancers Using PSMA-Targeted Radiotracers: Rationale, Current State of the Field, and a Call to Arms
Roberto A. Salas Fragomeni, Tali Amir, Sara Sheikhbahaei, Susan C. Harvey, Mehrbod S. Javadi, Lilja B. Solnes, Ana P. Kiess, Mohamad E. Allaf, Martin G. Pomper, Michael A. Gorin and Steven P. Rowe

Journal of Nuclear Medicine June 1, 2018, 59 (6) 871-877; DOI: https://doi.org/10.2967/jnumed.117.203570
You have access
Molecular Imaging in Cancer Drug Development
Stijn J.H. Waaijer, Iris C. Kok, Bertha Eisses, Carolina P. Schröder, Mathilde Jalving, Adrienne H. Brouwers, Marjolijn N. Lub-de Hooge and Elisabeth G.E. de Vries

Journal of Nuclear Medicine May 1, 2018, 59 (5) 726-732; DOI: https://doi.org/10.2967/jnumed.116.188045
You have access
¹⁸F-FDG PET/CT in Local Ablative Therapies: A Systematic Review
Erik H.J.G. Aarntzen, Linda Heijmen and Wim J.G. Oyen

Journal of Nuclear Medicine April 1, 2018, 59 (4) 551-556; DOI: https://doi.org/10.2967/jnumed.117.198184
You have access
Advanced Methods for Radiolabeling Multimodality Nanomedicines for SPECT/MRI and PET/MRI
Jennifer Lamb and Jason P. Holland

Journal of Nuclear Medicine March 1, 2018, 59 (3) 382-389; DOI: https://doi.org/10.2967/jnumed.116.187419
You have access
Why Targeting PSMA Is a Game Changer in the Management of Prostate Cancer
Nicholas M. Donin and Robert E. Reiter

Journal of Nuclear Medicine February 1, 2018, 59 (2) 177-182; DOI: https://doi.org/10.2967/jnumed.117.191874
You have access
Total-Body PET: Maximizing Sensitivity to Create New Opportunities for Clinical Research and Patient Care
Simon R. Cherry, Terry Jones, Joel S. Karp, Jinyi Qi, William W. Moses and Ramsey D. Badawi

Journal of Nuclear Medicine January 1, 2018, 59 (1) 3-12; DOI: https://doi.org/10.2967/jnumed.116.184028
You have access
In Vitro Evaluation of Molecular Tumor Targets in Nuclear Medicine: Immunohistochemistry Is One Option, but Under Which Conditions?
Jean Claude Reubi

Journal of Nuclear Medicine December 1, 2017, 58 (12) 1885-1887; DOI: https://doi.org/10.2967/jnumed.117.197582

Main menu

User menu

Search

More articles from The State of the Art

Pages